Portal de Periódicos da CAPES

Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption

2021; American Association for the Advancement of Science; Volume: 13; Issue: 576 Linguagem: Inglês

10.1126/scitranslmed.abd8179

1946-6242

Marcos V. P. Gondim, Scott Sherrill-Mix, Frédéric Bibollet‐Ruche, Ronnie M. Russell, Stephanie Trimboli, Andrew G. Smith, Yingying Li, Weimin Liu, Alexa N. Avitto, Julia C. DeVoto, Andrew Connell, Angharad E. Fenton-May, Pierre Pellegrino, Ian Williams, Emmanouil Papasavvas, Julio C. C. Lorenzi, D. Brenda Salantes, Felicity Mampe, M. Alexandra Monroy, Yehuda Z. Cohen, Sonya L. Heath, Michael S. Saag, Luis J. Montaner, Ronald G. Collman, Janet D. Siliciano, Robert F. Siliciano, Lindsey J. Plenderleith, Paul M. Sharp, Marina Caskey, Michel C. Nussenzweig, George M. Shaw, Persephone Borrow, Katharine J. Bar, Beatrice H. Hahn,

Immune Cell Function and Interaction

Interferon-mediated pressures vary throughout HIV-1 infection but are the highest during viral rebound after treatment interruption.